Text Size

Ocular surface response of two preservative-free cylcosporine A emulsion eye drops in a mouse model of dry eye

Daull P., Nagano T., Gros E., Feraille L., Barabino S., Garrigue J.-S.


  • 2021
  • Current Eye Research
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Technology

    Drug Delivery

  • Categories

    Preclinical development

  • Affiliations

    Daull, P., Ophthalmic Innovation Center, SANTEN SAS, Evry, France; Nagano, T., Research and Development Division, SANTEN Pharmaceutical Co., Ltd, Osaka, Japan; Gros, E., Les Nertières, Allée Hector Pintus, La Gaude, France; Feraille, L., Les Nertières, Allée Hector Pintus, La Gaude, France; Barabino, S., Ocular Surface and Dry Eye Center, Ospedale L, Sacco, Italy, University of Milan, Milan, Italy; Garrigue, J.-S., Ophthalmic Innovation Center, SANTEN SAS, Evry, France

Related Publications

Review of Preclinical Outcomes of a Topical Cationic Emulsion of Cyclosporine A for the Treatment of Ocular Surface Diseases

Daull P., Baudouin C., Liang H., Feraille L., Barabino S., Garrigue J.-S.


Safety and tolerability of overdosed artificial tears by abraded rabbit corneas

Daull P., Raymond E., Feraille L., Garrigue J.-S.


Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022